<code id='4AC0B9E893'></code><style id='4AC0B9E893'></style>
    • <acronym id='4AC0B9E893'></acronym>
      <center id='4AC0B9E893'><center id='4AC0B9E893'><tfoot id='4AC0B9E893'></tfoot></center><abbr id='4AC0B9E893'><dir id='4AC0B9E893'><tfoot id='4AC0B9E893'></tfoot><noframes id='4AC0B9E893'>

    • <optgroup id='4AC0B9E893'><strike id='4AC0B9E893'><sup id='4AC0B9E893'></sup></strike><code id='4AC0B9E893'></code></optgroup>
        1. <b id='4AC0B9E893'><label id='4AC0B9E893'><select id='4AC0B9E893'><dt id='4AC0B9E893'><span id='4AC0B9E893'></span></dt></select></label></b><u id='4AC0B9E893'></u>
          <i id='4AC0B9E893'><strike id='4AC0B9E893'><tt id='4AC0B9E893'><pre id='4AC0B9E893'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:89853
          Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT
          David J. Phillip/AP

          It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

          But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

          advertisement

          Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          2023 Nobel Prize in Medicine goes to Karikó and Weissman
          2023 Nobel Prize in Medicine goes to Karikó and Weissman

          AssociatedPressLONDON—TwopioneersofmRNAresearch—thetechnologythathelpedtheworldtamethevirusbehindthe

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Boeing's 1st astronaut flight bumped into next year, more repairs needed

          FILE-AUnitedLaunchAllianceAtlasVrocketwithBoeing'sCST-100StarlinerspacecraftisrolledoutoftheVertical